HRSA loan repayment program aims to boost opioid treatment access

Jan 07, 2019 - 02:49 PM
hrsa-service-corps

The Health Resources and Services Administration recently launched a program to provide eligible health care clinicians with student loan repayment assistance in exchange for their service on the front lines of the opioid crisis in underserved communities. The National Health Service Corps Substance Use Disorder Workforce Loan Repayment Program will boost access to preventive, treatment and recovery services for those struggling with substance use disorder, according to HRSA. Clinicians accepted to the program may receive up to $75,000 for three years of full-time service at a health care facility that has been designated by HRSA as an NHSC-approved substance use disorder site. A part-time service option also is available. Applications are due Feb. 21. 
 

Related News Articles

Headline
Senate passes SUPPORT Act reauthorization bill, moves to president for signing into law
The Senate Sept. 18 passed the AHA-supported SUPPORT Act (H.R. 2483) by a voice vote, advancing the bill to President Trump to sign into law. The bill…
Headline
AHA podcast: Destigmatizing Mental Health for Health Care Workers
Corey Feist, CEO and co-founder of the Dr. Lorna Breen Heroes Foundation, and Tiffany Lyttle, R.N., director of cultural integration at Centra Health, discuss…
Headline
U.S. uninsured rate increased between 2023 and 2024
The Census Bureau reported (https://www2.census.gov/library/publications/2025/demo/acsbr-024.pdf) that the uninsured rate increased nationally to 8.2% in 2024…
Headline
Survey finds nearly 48 million experiencing depression
A Gallup report published Sept. 9 found that nearly 48 million Americans currently have or are being treated for depression. The total, which equals 18.3% of…
Headline
FDA issues guidance to expand non-opioid treatments for chronic pain
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
AHA urges FTC, DOJ to investigate anticompetitive activity by drug companies on 340B rebate models 
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…